Experimental CAR t therapy targets tough myeloma cases
Disease control
Terminated
This early study tested a new treatment called Descartes-15 for people with multiple myeloma that came back or didn't respond to standard therapies. Descartes-15 uses a patient's own immune cells, engineered to recognize and attack myeloma cells. The trial was very small (4 parti…
Phase: PHASE1 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC